nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—CYP2D6—Fingolimod—multiple sclerosis	0.142	0.261	CbGbCtD
Tiotropium—CYP3A4—Fingolimod—multiple sclerosis	0.0906	0.166	CbGbCtD
Tiotropium—CYP3A4—Methylprednisolone—multiple sclerosis	0.0584	0.107	CbGbCtD
Tiotropium—CYP3A4—Triamcinolone—multiple sclerosis	0.0442	0.0811	CbGbCtD
Tiotropium—CYP3A4—Mitoxantrone—multiple sclerosis	0.0426	0.078	CbGbCtD
Tiotropium—CYP3A4—Betamethasone—multiple sclerosis	0.038	0.0695	CbGbCtD
Tiotropium—CYP3A4—Prednisolone—multiple sclerosis	0.0375	0.0686	CbGbCtD
Tiotropium—CYP3A4—Prednisone—multiple sclerosis	0.0354	0.0648	CbGbCtD
Tiotropium—CYP2D6—Dexamethasone—multiple sclerosis	0.0347	0.0636	CbGbCtD
Tiotropium—CYP3A4—Dexamethasone—multiple sclerosis	0.0221	0.0405	CbGbCtD
Tiotropium—Aclidinium—BCHE—multiple sclerosis	0.00775	1	CrCbGaD
Tiotropium—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000809	0.00209	CcSEcCtD
Tiotropium—Arrhythmia—Prednisolone—multiple sclerosis	0.000802	0.00207	CcSEcCtD
Tiotropium—Visual impairment—Methylprednisolone—multiple sclerosis	0.000794	0.00205	CcSEcCtD
Tiotropium—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000786	0.00203	CcSEcCtD
Tiotropium—Dizziness—Cladribine—multiple sclerosis	0.000782	0.00202	CcSEcCtD
Tiotropium—Oedema—Mitoxantrone—multiple sclerosis	0.000777	0.00201	CcSEcCtD
Tiotropium—Infection—Mitoxantrone—multiple sclerosis	0.000772	0.00199	CcSEcCtD
Tiotropium—Eye disorder—Methylprednisolone—multiple sclerosis	0.00077	0.00199	CcSEcCtD
Tiotropium—Shock—Mitoxantrone—multiple sclerosis	0.000765	0.00197	CcSEcCtD
Tiotropium—Abdominal pain—Azathioprine—multiple sclerosis	0.00076	0.00196	CcSEcCtD
Tiotropium—Tachycardia—Mitoxantrone—multiple sclerosis	0.000758	0.00196	CcSEcCtD
Tiotropium—Skin disorder—Mitoxantrone—multiple sclerosis	0.000755	0.00195	CcSEcCtD
Tiotropium—Vomiting—Cladribine—multiple sclerosis	0.000752	0.00194	CcSEcCtD
Tiotropium—Angiopathy—Methylprednisolone—multiple sclerosis	0.000747	0.00193	CcSEcCtD
Tiotropium—Rash—Cladribine—multiple sclerosis	0.000745	0.00192	CcSEcCtD
Tiotropium—Dermatitis—Cladribine—multiple sclerosis	0.000745	0.00192	CcSEcCtD
Tiotropium—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000744	0.00192	CcSEcCtD
Tiotropium—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000742	0.00192	CcSEcCtD
Tiotropium—Headache—Cladribine—multiple sclerosis	0.000741	0.00191	CcSEcCtD
Tiotropium—Arrhythmia—Triamcinolone—multiple sclerosis	0.000737	0.0019	CcSEcCtD
Tiotropium—Vision blurred—Prednisolone—multiple sclerosis	0.000736	0.0019	CcSEcCtD
Tiotropium—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000736	0.0019	CcSEcCtD
Tiotropium—Hyperglycaemia—Prednisone—multiple sclerosis	0.000735	0.0019	CcSEcCtD
Tiotropium—Visual impairment—Dexamethasone—multiple sclerosis	0.000722	0.00186	CcSEcCtD
Tiotropium—Visual impairment—Betamethasone—multiple sclerosis	0.000722	0.00186	CcSEcCtD
Tiotropium—Mental disorder—Methylprednisolone—multiple sclerosis	0.000721	0.00186	CcSEcCtD
Tiotropium—Malnutrition—Methylprednisolone—multiple sclerosis	0.000717	0.00185	CcSEcCtD
Tiotropium—Angioedema—Prednisolone—multiple sclerosis	0.000714	0.00184	CcSEcCtD
Tiotropium—Hypersensitivity—Azathioprine—multiple sclerosis	0.000708	0.00183	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000708	0.00183	CcSEcCtD
Tiotropium—Nausea—Cladribine—multiple sclerosis	0.000702	0.00181	CcSEcCtD
Tiotropium—Syncope—Prednisolone—multiple sclerosis	0.000701	0.00181	CcSEcCtD
Tiotropium—Eye disorder—Dexamethasone—multiple sclerosis	0.0007	0.00181	CcSEcCtD
Tiotropium—Eye disorder—Betamethasone—multiple sclerosis	0.0007	0.00181	CcSEcCtD
Tiotropium—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000698	0.0018	CcSEcCtD
Tiotropium—Back pain—Triamcinolone—multiple sclerosis	0.000695	0.00179	CcSEcCtD
Tiotropium—Loss of consciousness—Prednisolone—multiple sclerosis	0.000687	0.00177	CcSEcCtD
Tiotropium—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000684	0.00177	CcSEcCtD
Tiotropium—Angiopathy—Betamethasone—multiple sclerosis	0.000679	0.00175	CcSEcCtD
Tiotropium—Angiopathy—Dexamethasone—multiple sclerosis	0.000679	0.00175	CcSEcCtD
Tiotropium—Hypertension—Prednisolone—multiple sclerosis	0.000674	0.00174	CcSEcCtD
Tiotropium—Arrhythmia—Dexamethasone—multiple sclerosis	0.000669	0.00173	CcSEcCtD
Tiotropium—Arrhythmia—Betamethasone—multiple sclerosis	0.000669	0.00173	CcSEcCtD
Tiotropium—Constipation—Mitoxantrone—multiple sclerosis	0.000665	0.00172	CcSEcCtD
Tiotropium—Angioedema—Triamcinolone—multiple sclerosis	0.000656	0.00169	CcSEcCtD
Tiotropium—Angioedema—Methylprednisolone—multiple sclerosis	0.000655	0.00169	CcSEcCtD
Tiotropium—Syncope—Triamcinolone—multiple sclerosis	0.000644	0.00166	CcSEcCtD
Tiotropium—Syncope—Methylprednisolone—multiple sclerosis	0.000643	0.00166	CcSEcCtD
Tiotropium—Connective tissue disorder—Prednisone—multiple sclerosis	0.000641	0.00165	CcSEcCtD
Tiotropium—Oedema—Prednisolone—multiple sclerosis	0.000638	0.00165	CcSEcCtD
Tiotropium—Dysuria—Methotrexate—multiple sclerosis	0.000637	0.00164	CcSEcCtD
Tiotropium—Dizziness—Azathioprine—multiple sclerosis	0.000636	0.00164	CcSEcCtD
Tiotropium—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000636	0.00164	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000633	0.00163	CcSEcCtD
Tiotropium—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000631	0.00163	CcSEcCtD
Tiotropium—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00063	0.00163	CcSEcCtD
Tiotropium—Shock—Prednisolone—multiple sclerosis	0.000627	0.00162	CcSEcCtD
Tiotropium—Cough—Triamcinolone—multiple sclerosis	0.000627	0.00162	CcSEcCtD
Tiotropium—Tachycardia—Prednisolone—multiple sclerosis	0.000622	0.00161	CcSEcCtD
Tiotropium—Hypertension—Triamcinolone—multiple sclerosis	0.00062	0.0016	CcSEcCtD
Tiotropium—Hypertension—Methylprednisolone—multiple sclerosis	0.000619	0.0016	CcSEcCtD
Tiotropium—Urticaria—Mitoxantrone—multiple sclerosis	0.000617	0.00159	CcSEcCtD
Tiotropium—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000614	0.00159	CcSEcCtD
Tiotropium—Myalgia—Triamcinolone—multiple sclerosis	0.000612	0.00158	CcSEcCtD
Tiotropium—Vomiting—Azathioprine—multiple sclerosis	0.000611	0.00158	CcSEcCtD
Tiotropium—Myalgia—Methylprednisolone—multiple sclerosis	0.00061	0.00158	CcSEcCtD
Tiotropium—Arthralgia—Methylprednisolone—multiple sclerosis	0.00061	0.00158	CcSEcCtD
Tiotropium—Eye disorder—Prednisone—multiple sclerosis	0.000609	0.00157	CcSEcCtD
Tiotropium—Rash—Azathioprine—multiple sclerosis	0.000606	0.00156	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000606	0.00156	CcSEcCtD
Tiotropium—Dermatitis—Azathioprine—multiple sclerosis	0.000606	0.00156	CcSEcCtD
Tiotropium—Headache—Azathioprine—multiple sclerosis	0.000602	0.00155	CcSEcCtD
Tiotropium—Dry mouth—Triamcinolone—multiple sclerosis	0.000598	0.00154	CcSEcCtD
Tiotropium—Renal failure—Methotrexate—multiple sclerosis	0.000597	0.00154	CcSEcCtD
Tiotropium—Angioedema—Betamethasone—multiple sclerosis	0.000596	0.00154	CcSEcCtD
Tiotropium—Angioedema—Dexamethasone—multiple sclerosis	0.000596	0.00154	CcSEcCtD
Tiotropium—Stomatitis—Methotrexate—multiple sclerosis	0.000592	0.00153	CcSEcCtD
Tiotropium—Angiopathy—Prednisone—multiple sclerosis	0.000592	0.00153	CcSEcCtD
Tiotropium—Immune system disorder—Prednisone—multiple sclerosis	0.000589	0.00152	CcSEcCtD
Tiotropium—Oedema—Triamcinolone—multiple sclerosis	0.000586	0.00151	CcSEcCtD
Tiotropium—Syncope—Dexamethasone—multiple sclerosis	0.000585	0.00151	CcSEcCtD
Tiotropium—Syncope—Betamethasone—multiple sclerosis	0.000585	0.00151	CcSEcCtD
Tiotropium—Arrhythmia—Prednisone—multiple sclerosis	0.000583	0.0015	CcSEcCtD
Tiotropium—Infection—Triamcinolone—multiple sclerosis	0.000583	0.0015	CcSEcCtD
Tiotropium—Infection—Methylprednisolone—multiple sclerosis	0.000581	0.0015	CcSEcCtD
Tiotropium—Shock—Triamcinolone—multiple sclerosis	0.000577	0.00149	CcSEcCtD
Tiotropium—Insomnia—Prednisolone—multiple sclerosis	0.000577	0.00149	CcSEcCtD
Tiotropium—Shock—Methylprednisolone—multiple sclerosis	0.000576	0.00149	CcSEcCtD
Tiotropium—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000574	0.00148	CcSEcCtD
Tiotropium—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000573	0.00148	CcSEcCtD
Tiotropium—Loss of consciousness—Betamethasone—multiple sclerosis	0.000573	0.00148	CcSEcCtD
Tiotropium—Epistaxis—Methotrexate—multiple sclerosis	0.000573	0.00148	CcSEcCtD
Tiotropium—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000573	0.00148	CcSEcCtD
Tiotropium—Paraesthesia—Prednisolone—multiple sclerosis	0.000573	0.00148	CcSEcCtD
Tiotropium—Tachycardia—Triamcinolone—multiple sclerosis	0.000572	0.00148	CcSEcCtD
Tiotropium—Mental disorder—Prednisone—multiple sclerosis	0.000571	0.00147	CcSEcCtD
Tiotropium—Nausea—Azathioprine—multiple sclerosis	0.000571	0.00147	CcSEcCtD
Tiotropium—Tachycardia—Methylprednisolone—multiple sclerosis	0.000571	0.00147	CcSEcCtD
Tiotropium—Skin disorder—Methylprednisolone—multiple sclerosis	0.000568	0.00147	CcSEcCtD
Tiotropium—Malnutrition—Prednisone—multiple sclerosis	0.000568	0.00147	CcSEcCtD
Tiotropium—Hypertension—Betamethasone—multiple sclerosis	0.000563	0.00145	CcSEcCtD
Tiotropium—Hypertension—Dexamethasone—multiple sclerosis	0.000563	0.00145	CcSEcCtD
Tiotropium—Myalgia—Dexamethasone—multiple sclerosis	0.000555	0.00143	CcSEcCtD
Tiotropium—Myalgia—Betamethasone—multiple sclerosis	0.000555	0.00143	CcSEcCtD
Tiotropium—Pharyngitis—Methotrexate—multiple sclerosis	0.000541	0.0014	CcSEcCtD
Tiotropium—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000538	0.00139	CcSEcCtD
Tiotropium—Vision blurred—Prednisone—multiple sclerosis	0.000535	0.00138	CcSEcCtD
Tiotropium—Urethral disorder—Methotrexate—multiple sclerosis	0.000534	0.00138	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000534	0.00138	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000533	0.00138	CcSEcCtD
Tiotropium—Oedema—Betamethasone—multiple sclerosis	0.000532	0.00137	CcSEcCtD
Tiotropium—Oedema—Dexamethasone—multiple sclerosis	0.000532	0.00137	CcSEcCtD
Tiotropium—Insomnia—Triamcinolone—multiple sclerosis	0.00053	0.00137	CcSEcCtD
Tiotropium—Insomnia—Methylprednisolone—multiple sclerosis	0.000529	0.00137	CcSEcCtD
Tiotropium—Infection—Betamethasone—multiple sclerosis	0.000529	0.00136	CcSEcCtD
Tiotropium—Infection—Dexamethasone—multiple sclerosis	0.000529	0.00136	CcSEcCtD
Tiotropium—Paraesthesia—Triamcinolone—multiple sclerosis	0.000526	0.00136	CcSEcCtD
Tiotropium—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000525	0.00136	CcSEcCtD
Tiotropium—Visual impairment—Methotrexate—multiple sclerosis	0.000525	0.00136	CcSEcCtD
Tiotropium—Shock—Betamethasone—multiple sclerosis	0.000523	0.00135	CcSEcCtD
Tiotropium—Shock—Dexamethasone—multiple sclerosis	0.000523	0.00135	CcSEcCtD
Tiotropium—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000522	0.00135	CcSEcCtD
Tiotropium—Nervous system disorder—Betamethasone—multiple sclerosis	0.000522	0.00135	CcSEcCtD
Tiotropium—Tachycardia—Dexamethasone—multiple sclerosis	0.000519	0.00134	CcSEcCtD
Tiotropium—Tachycardia—Betamethasone—multiple sclerosis	0.000519	0.00134	CcSEcCtD
Tiotropium—Angioedema—Prednisone—multiple sclerosis	0.000519	0.00134	CcSEcCtD
Tiotropium—Dyspepsia—Triamcinolone—multiple sclerosis	0.000516	0.00133	CcSEcCtD
Tiotropium—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000515	0.00133	CcSEcCtD
Tiotropium—Eye disorder—Methotrexate—multiple sclerosis	0.000509	0.00131	CcSEcCtD
Tiotropium—Syncope—Prednisone—multiple sclerosis	0.000509	0.00131	CcSEcCtD
Tiotropium—Urticaria—Prednisolone—multiple sclerosis	0.000507	0.00131	CcSEcCtD
Tiotropium—Loss of consciousness—Prednisone—multiple sclerosis	0.000499	0.00129	CcSEcCtD
Tiotropium—Angiopathy—Methotrexate—multiple sclerosis	0.000494	0.00128	CcSEcCtD
Tiotropium—Vomiting—Mitoxantrone—multiple sclerosis	0.000494	0.00128	CcSEcCtD
Tiotropium—Immune system disorder—Methotrexate—multiple sclerosis	0.000492	0.00127	CcSEcCtD
Tiotropium—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000491	0.00127	CcSEcCtD
Tiotropium—Hypertension—Prednisone—multiple sclerosis	0.00049	0.00127	CcSEcCtD
Tiotropium—Rash—Mitoxantrone—multiple sclerosis	0.00049	0.00126	CcSEcCtD
Tiotropium—Dermatitis—Mitoxantrone—multiple sclerosis	0.00049	0.00126	CcSEcCtD
Tiotropium—Headache—Mitoxantrone—multiple sclerosis	0.000487	0.00126	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000485	0.00125	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000485	0.00125	CcSEcCtD
Tiotropium—Arthralgia—Prednisone—multiple sclerosis	0.000483	0.00125	CcSEcCtD
Tiotropium—Myalgia—Prednisone—multiple sclerosis	0.000483	0.00125	CcSEcCtD
Tiotropium—Insomnia—Dexamethasone—multiple sclerosis	0.000481	0.00124	CcSEcCtD
Tiotropium—Insomnia—Betamethasone—multiple sclerosis	0.000481	0.00124	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00048	0.00124	CcSEcCtD
Tiotropium—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000478	0.00123	CcSEcCtD
Tiotropium—Paraesthesia—Betamethasone—multiple sclerosis	0.000478	0.00123	CcSEcCtD
Tiotropium—Paraesthesia—Dexamethasone—multiple sclerosis	0.000478	0.00123	CcSEcCtD
Tiotropium—Mental disorder—Methotrexate—multiple sclerosis	0.000477	0.00123	CcSEcCtD
Tiotropium—Malnutrition—Methotrexate—multiple sclerosis	0.000474	0.00122	CcSEcCtD
Tiotropium—Hypersensitivity—Prednisolone—multiple sclerosis	0.00047	0.00121	CcSEcCtD
Tiotropium—Dyspepsia—Betamethasone—multiple sclerosis	0.000468	0.00121	CcSEcCtD
Tiotropium—Dyspepsia—Dexamethasone—multiple sclerosis	0.000468	0.00121	CcSEcCtD
Tiotropium—Urticaria—Triamcinolone—multiple sclerosis	0.000466	0.0012	CcSEcCtD
Tiotropium—Urticaria—Methylprednisolone—multiple sclerosis	0.000465	0.0012	CcSEcCtD
Tiotropium—Oedema—Prednisone—multiple sclerosis	0.000463	0.0012	CcSEcCtD
Tiotropium—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000462	0.00119	CcSEcCtD
Tiotropium—Nausea—Mitoxantrone—multiple sclerosis	0.000462	0.00119	CcSEcCtD
Tiotropium—Infection—Prednisone—multiple sclerosis	0.00046	0.00119	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000459	0.00119	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000459	0.00119	CcSEcCtD
Tiotropium—Back pain—Methotrexate—multiple sclerosis	0.000459	0.00118	CcSEcCtD
Tiotropium—Shock—Prednisone—multiple sclerosis	0.000456	0.00118	CcSEcCtD
Tiotropium—Nervous system disorder—Prednisone—multiple sclerosis	0.000454	0.00117	CcSEcCtD
Tiotropium—Tachycardia—Prednisone—multiple sclerosis	0.000452	0.00117	CcSEcCtD
Tiotropium—Skin disorder—Prednisone—multiple sclerosis	0.00045	0.00116	CcSEcCtD
Tiotropium—Vision blurred—Methotrexate—multiple sclerosis	0.000447	0.00115	CcSEcCtD
Tiotropium—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000435	0.00112	CcSEcCtD
Tiotropium—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000435	0.00112	CcSEcCtD
Tiotropium—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000432	0.00111	CcSEcCtD
Tiotropium—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000431	0.00111	CcSEcCtD
Tiotropium—Urticaria—Betamethasone—multiple sclerosis	0.000423	0.00109	CcSEcCtD
Tiotropium—Urticaria—Dexamethasone—multiple sclerosis	0.000423	0.00109	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000422	0.00109	CcSEcCtD
Tiotropium—Dizziness—Prednisolone—multiple sclerosis	0.000422	0.00109	CcSEcCtD
Tiotropium—Abdominal pain—Dexamethasone—multiple sclerosis	0.000421	0.00109	CcSEcCtD
Tiotropium—Abdominal pain—Betamethasone—multiple sclerosis	0.000421	0.00109	CcSEcCtD
Tiotropium—Insomnia—Prednisone—multiple sclerosis	0.000419	0.00108	CcSEcCtD
Tiotropium—Paraesthesia—Prednisone—multiple sclerosis	0.000416	0.00107	CcSEcCtD
Tiotropium—Pruritus—Triamcinolone—multiple sclerosis	0.000415	0.00107	CcSEcCtD
Tiotropium—Cough—Methotrexate—multiple sclerosis	0.000414	0.00107	CcSEcCtD
Tiotropium—Pruritus—Methylprednisolone—multiple sclerosis	0.000414	0.00107	CcSEcCtD
Tiotropium—Dyspepsia—Prednisone—multiple sclerosis	0.000408	0.00105	CcSEcCtD
Tiotropium—Chest pain—Methotrexate—multiple sclerosis	0.000404	0.00104	CcSEcCtD
Tiotropium—Arthralgia—Methotrexate—multiple sclerosis	0.000404	0.00104	CcSEcCtD
Tiotropium—Myalgia—Methotrexate—multiple sclerosis	0.000404	0.00104	CcSEcCtD
Tiotropium—Rash—Prednisolone—multiple sclerosis	0.000402	0.00104	CcSEcCtD
Tiotropium—Dermatitis—Prednisolone—multiple sclerosis	0.000402	0.00104	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000401	0.00104	CcSEcCtD
Tiotropium—Headache—Prednisolone—multiple sclerosis	0.000399	0.00103	CcSEcCtD
Tiotropium—Constipation—Prednisone—multiple sclerosis	0.000396	0.00102	CcSEcCtD
Tiotropium—Dizziness—Triamcinolone—multiple sclerosis	0.000388	0.001	CcSEcCtD
Tiotropium—Dizziness—Methylprednisolone—multiple sclerosis	0.000387	0.000999	CcSEcCtD
Tiotropium—Infection—Methotrexate—multiple sclerosis	0.000385	0.000993	CcSEcCtD
Tiotropium—Nervous system disorder—Methotrexate—multiple sclerosis	0.00038	0.00098	CcSEcCtD
Tiotropium—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000379	0.000978	CcSEcCtD
Tiotropium—Nausea—Prednisolone—multiple sclerosis	0.000379	0.000977	CcSEcCtD
Tiotropium—Pruritus—Betamethasone—multiple sclerosis	0.000376	0.000971	CcSEcCtD
Tiotropium—Pruritus—Dexamethasone—multiple sclerosis	0.000376	0.000971	CcSEcCtD
Tiotropium—Skin disorder—Methotrexate—multiple sclerosis	0.000376	0.000971	CcSEcCtD
Tiotropium—Vomiting—Triamcinolone—multiple sclerosis	0.000373	0.000962	CcSEcCtD
Tiotropium—Vomiting—Methylprednisolone—multiple sclerosis	0.000372	0.00096	CcSEcCtD
Tiotropium—Rash—Triamcinolone—multiple sclerosis	0.00037	0.000954	CcSEcCtD
Tiotropium—Dermatitis—Triamcinolone—multiple sclerosis	0.000369	0.000953	CcSEcCtD
Tiotropium—Rash—Methylprednisolone—multiple sclerosis	0.000369	0.000952	CcSEcCtD
Tiotropium—Dermatitis—Methylprednisolone—multiple sclerosis	0.000369	0.000951	CcSEcCtD
Tiotropium—Urticaria—Prednisone—multiple sclerosis	0.000368	0.00095	CcSEcCtD
Tiotropium—Headache—Triamcinolone—multiple sclerosis	0.000367	0.000948	CcSEcCtD
Tiotropium—Headache—Methylprednisolone—multiple sclerosis	0.000367	0.000946	CcSEcCtD
Tiotropium—Abdominal pain—Prednisone—multiple sclerosis	0.000366	0.000945	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000353	0.000911	CcSEcCtD
Tiotropium—Dizziness—Dexamethasone—multiple sclerosis	0.000352	0.000908	CcSEcCtD
Tiotropium—Dizziness—Betamethasone—multiple sclerosis	0.000352	0.000908	CcSEcCtD
Tiotropium—Insomnia—Methotrexate—multiple sclerosis	0.00035	0.000904	CcSEcCtD
Tiotropium—Nausea—Triamcinolone—multiple sclerosis	0.000348	0.000899	CcSEcCtD
Tiotropium—Paraesthesia—Methotrexate—multiple sclerosis	0.000348	0.000897	CcSEcCtD
Tiotropium—Nausea—Methylprednisolone—multiple sclerosis	0.000348	0.000897	CcSEcCtD
Tiotropium—Hypersensitivity—Prednisone—multiple sclerosis	0.000341	0.000881	CcSEcCtD
Tiotropium—Dyspepsia—Methotrexate—multiple sclerosis	0.000341	0.00088	CcSEcCtD
Tiotropium—Vomiting—Betamethasone—multiple sclerosis	0.000338	0.000873	CcSEcCtD
Tiotropium—Vomiting—Dexamethasone—multiple sclerosis	0.000338	0.000873	CcSEcCtD
Tiotropium—Rash—Betamethasone—multiple sclerosis	0.000335	0.000866	CcSEcCtD
Tiotropium—Rash—Dexamethasone—multiple sclerosis	0.000335	0.000866	CcSEcCtD
Tiotropium—Dermatitis—Dexamethasone—multiple sclerosis	0.000335	0.000865	CcSEcCtD
Tiotropium—Dermatitis—Betamethasone—multiple sclerosis	0.000335	0.000865	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000334	0.000863	CcSEcCtD
Tiotropium—Headache—Dexamethasone—multiple sclerosis	0.000333	0.00086	CcSEcCtD
Tiotropium—Headache—Betamethasone—multiple sclerosis	0.000333	0.00086	CcSEcCtD
Tiotropium—Pruritus—Prednisone—multiple sclerosis	0.000328	0.000846	CcSEcCtD
Tiotropium—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000317	0.000817	CcSEcCtD
Tiotropium—Nausea—Dexamethasone—multiple sclerosis	0.000316	0.000816	CcSEcCtD
Tiotropium—Nausea—Betamethasone—multiple sclerosis	0.000316	0.000816	CcSEcCtD
Tiotropium—Urticaria—Methotrexate—multiple sclerosis	0.000308	0.000794	CcSEcCtD
Tiotropium—Dizziness—Prednisone—multiple sclerosis	0.000306	0.000791	CcSEcCtD
Tiotropium—Abdominal pain—Methotrexate—multiple sclerosis	0.000306	0.00079	CcSEcCtD
Tiotropium—Vomiting—Prednisone—multiple sclerosis	0.000295	0.00076	CcSEcCtD
Tiotropium—Rash—Prednisone—multiple sclerosis	0.000292	0.000754	CcSEcCtD
Tiotropium—Dermatitis—Prednisone—multiple sclerosis	0.000292	0.000753	CcSEcCtD
Tiotropium—Headache—Prednisone—multiple sclerosis	0.00029	0.000749	CcSEcCtD
Tiotropium—Hypersensitivity—Methotrexate—multiple sclerosis	0.000285	0.000736	CcSEcCtD
Tiotropium—Nausea—Prednisone—multiple sclerosis	0.000275	0.00071	CcSEcCtD
Tiotropium—Pruritus—Methotrexate—multiple sclerosis	0.000274	0.000707	CcSEcCtD
Tiotropium—Dizziness—Methotrexate—multiple sclerosis	0.000256	0.000661	CcSEcCtD
Tiotropium—Vomiting—Methotrexate—multiple sclerosis	0.000246	0.000635	CcSEcCtD
Tiotropium—Rash—Methotrexate—multiple sclerosis	0.000244	0.00063	CcSEcCtD
Tiotropium—Dermatitis—Methotrexate—multiple sclerosis	0.000244	0.00063	CcSEcCtD
Tiotropium—Headache—Methotrexate—multiple sclerosis	0.000243	0.000626	CcSEcCtD
Tiotropium—Nausea—Methotrexate—multiple sclerosis	0.00023	0.000594	CcSEcCtD
Tiotropium—CHRM1—GPCR ligand binding—CCR5—multiple sclerosis	5.47e-05	0.000929	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—CCR5—multiple sclerosis	5.45e-05	0.000926	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	5.42e-05	0.00092	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—S1PR1—multiple sclerosis	5.42e-05	0.00092	CbGpPWpGaD
Tiotropium—CYP2D6—Biological oxidations—POMC—multiple sclerosis	5.4e-05	0.000917	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	5.4e-05	0.000917	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—S1PR1—multiple sclerosis	5.4e-05	0.000917	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	5.35e-05	0.000908	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—GPC5—multiple sclerosis	5.27e-05	0.000894	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—GPC5—multiple sclerosis	5.25e-05	0.000892	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	5.21e-05	0.000884	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—RRM1—multiple sclerosis	5.21e-05	0.000884	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	5.2e-05	0.000883	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—CXCL10—multiple sclerosis	5.14e-05	0.000873	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	5.11e-05	0.000867	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—PTGER4—multiple sclerosis	5.09e-05	0.000864	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	5.04e-05	0.000856	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	4.93e-05	0.000837	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CXCR3—multiple sclerosis	4.92e-05	0.000834	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—CCL5—multiple sclerosis	4.88e-05	0.000827	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	4.87e-05	0.000826	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CCL3—multiple sclerosis	4.82e-05	0.000818	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CCL3—multiple sclerosis	4.8e-05	0.000815	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CCR2—multiple sclerosis	4.8e-05	0.000814	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CCR2—multiple sclerosis	4.78e-05	0.000812	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	4.76e-05	0.000807	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	4.74e-05	0.000804	CbGpPWpGaD
Tiotropium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	4.68e-05	0.000794	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PTGER4—multiple sclerosis	4.64e-05	0.000787	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PTGER4—multiple sclerosis	4.62e-05	0.000785	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RGS1—multiple sclerosis	4.61e-05	0.000782	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RGS1—multiple sclerosis	4.59e-05	0.000779	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	4.58e-05	0.000777	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	4.55e-05	0.000772	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CXCR3—multiple sclerosis	4.48e-05	0.00076	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CXCR3—multiple sclerosis	4.47e-05	0.000758	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CNR1—multiple sclerosis	4.43e-05	0.000751	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—CCL5—multiple sclerosis	4.43e-05	0.000751	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	4.42e-05	0.00075	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CNR1—multiple sclerosis	4.41e-05	0.000749	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—CCR5—multiple sclerosis	4.39e-05	0.000745	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	4.37e-05	0.000742	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—GPR65—multiple sclerosis	4.37e-05	0.000741	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CCR2—multiple sclerosis	4.36e-05	0.000739	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—GPR65—multiple sclerosis	4.35e-05	0.000739	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CCR2—multiple sclerosis	4.34e-05	0.000737	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—IL2RA—multiple sclerosis	4.33e-05	0.000734	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	4.31e-05	0.000732	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	4.3e-05	0.00073	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	4.29e-05	0.000728	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	4.28e-05	0.000726	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	4.28e-05	0.000725	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—POMC—multiple sclerosis	4.26e-05	0.000723	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	4.22e-05	0.000716	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	4.21e-05	0.000714	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	4.18e-05	0.00071	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—CCL2—multiple sclerosis	4.17e-05	0.000708	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	4.13e-05	0.000701	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	4.11e-05	0.000697	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	4.11e-05	0.000697	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CCL3—multiple sclerosis	4.04e-05	0.000686	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	4.02e-05	0.000682	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CNR1—multiple sclerosis	4.01e-05	0.00068	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	4e-05	0.000678	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	4e-05	0.000678	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—CCR5—multiple sclerosis	3.99e-05	0.000677	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	3.99e-05	0.000677	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCR1—multiple sclerosis	3.98e-05	0.000676	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CXCL13—multiple sclerosis	3.98e-05	0.000676	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CXCL10—multiple sclerosis	3.97e-05	0.000674	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	3.97e-05	0.000674	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	3.94e-05	0.000669	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	3.94e-05	0.000669	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	3.94e-05	0.000668	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—IL2RA—multiple sclerosis	3.93e-05	0.000667	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PTGER4—multiple sclerosis	3.89e-05	0.00066	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PGR—multiple sclerosis	3.83e-05	0.00065	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SRM—multiple sclerosis	3.81e-05	0.000647	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CXCR3—multiple sclerosis	3.76e-05	0.000638	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GPC5—multiple sclerosis	3.76e-05	0.000638	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CD28—multiple sclerosis	3.72e-05	0.000632	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CCR2—multiple sclerosis	3.66e-05	0.00062	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	3.62e-05	0.000614	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CXCL10—multiple sclerosis	3.61e-05	0.000612	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	3.57e-05	0.000607	CbGpPWpGaD
Tiotropium—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.53e-05	0.0006	CbGpPWpGaD
Tiotropium—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	3.48e-05	0.00059	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—POMC—multiple sclerosis	3.43e-05	0.000582	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	3.43e-05	0.000582	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CCL5—multiple sclerosis	3.42e-05	0.000581	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	3.39e-05	0.000575	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CNR1—multiple sclerosis	3.37e-05	0.000573	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.3e-05	0.000559	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.29e-05	0.000557	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—POMC—multiple sclerosis	3.12e-05	0.000529	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	3.12e-05	0.000529	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.11e-05	0.000528	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CCL5—multiple sclerosis	3.11e-05	0.000527	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	3.09e-05	0.000525	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CCR5—multiple sclerosis	3.08e-05	0.000523	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	3.08e-05	0.000522	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	3.05e-05	0.000518	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—CCL2—multiple sclerosis	3.05e-05	0.000518	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	3.05e-05	0.000517	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CXCL10—multiple sclerosis	3.04e-05	0.000516	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—IL2RA—multiple sclerosis	3.04e-05	0.000516	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	3.01e-05	0.000511	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—BCHE—multiple sclerosis	2.99e-05	0.000507	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	2.85e-05	0.000483	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCL3—multiple sclerosis	2.84e-05	0.000481	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	2.81e-05	0.000477	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	2.81e-05	0.000477	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CCR5—multiple sclerosis	2.8e-05	0.000475	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	2.77e-05	0.00047	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—TYK2—multiple sclerosis	2.77e-05	0.00047	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	2.77e-05	0.00047	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—IL2RA—multiple sclerosis	2.76e-05	0.000468	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	2.74e-05	0.000465	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	2.73e-05	0.000464	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PTGER4—multiple sclerosis	2.73e-05	0.000463	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	2.7e-05	0.000459	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PGR—multiple sclerosis	2.7e-05	0.000458	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PGR—multiple sclerosis	2.69e-05	0.000456	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.69e-05	0.000456	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.69e-05	0.000456	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PGR—multiple sclerosis	2.66e-05	0.000452	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CD86—multiple sclerosis	2.66e-05	0.000451	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	2.65e-05	0.000449	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CXCR3—multiple sclerosis	2.64e-05	0.000448	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CD28—multiple sclerosis	2.62e-05	0.000445	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CCL5—multiple sclerosis	2.62e-05	0.000444	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CD28—multiple sclerosis	2.61e-05	0.000443	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	2.61e-05	0.000443	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CD28—multiple sclerosis	2.59e-05	0.000439	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	2.57e-05	0.000437	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCR2—multiple sclerosis	2.57e-05	0.000435	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	2.54e-05	0.000431	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—IL2—multiple sclerosis	2.54e-05	0.000431	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.46e-05	0.000417	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SPP1—multiple sclerosis	2.42e-05	0.000411	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	2.42e-05	0.00041	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	2.41e-05	0.000409	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	2.39e-05	0.000405	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	2.38e-05	0.000403	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	2.37e-05	0.000402	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CCR5—multiple sclerosis	2.36e-05	0.0004	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	2.35e-05	0.000398	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IL2RA—multiple sclerosis	2.32e-05	0.000394	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—IL2—multiple sclerosis	2.3e-05	0.000391	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	2.19e-05	0.000372	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	2.19e-05	0.000371	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	2.17e-05	0.000368	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	2.15e-05	0.000364	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—APOE—multiple sclerosis	2.14e-05	0.000364	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	2.14e-05	0.000363	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	2.14e-05	0.000363	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	2.13e-05	0.000362	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	2.12e-05	0.00036	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	2.11e-05	0.000358	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.04e-05	0.000345	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	1.95e-05	0.000331	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	1.94e-05	0.00033	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CD80—multiple sclerosis	1.94e-05	0.000329	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	1.92e-05	0.000327	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CD86—multiple sclerosis	1.87e-05	0.000317	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CD86—multiple sclerosis	1.86e-05	0.000316	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CD86—multiple sclerosis	1.85e-05	0.000313	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—POMC—multiple sclerosis	1.84e-05	0.000312	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	1.84e-05	0.000312	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	1.84e-05	0.000311	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	1.82e-05	0.000308	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CCL2—multiple sclerosis	1.8e-05	0.000306	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—APOE—multiple sclerosis	1.8e-05	0.000305	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.79e-05	0.000303	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	1.79e-05	0.000303	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	1.78e-05	0.000302	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	1.76e-05	0.000299	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—MAPK1—multiple sclerosis	1.76e-05	0.000299	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	1.71e-05	0.000289	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	1.7e-05	0.000288	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	1.68e-05	0.000286	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	1.66e-05	0.000281	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	1.65e-05	0.000281	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	1.64e-05	0.000278	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TYK2—multiple sclerosis	1.64e-05	0.000278	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	1.63e-05	0.000277	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	1.63e-05	0.000277	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	1.62e-05	0.000275	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	1.62e-05	0.000274	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	1.61e-05	0.000274	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	1.6e-05	0.000272	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—POMC—multiple sclerosis	1.55e-05	0.000262	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—APOE—multiple sclerosis	1.51e-05	0.000256	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—APOE—multiple sclerosis	1.5e-05	0.000255	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—APOE—multiple sclerosis	1.49e-05	0.000253	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ALB—multiple sclerosis	1.41e-05	0.000239	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CD80—multiple sclerosis	1.36e-05	0.000232	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IL2—multiple sclerosis	1.36e-05	0.000231	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CD80—multiple sclerosis	1.36e-05	0.000231	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	1.35e-05	0.00023	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CD80—multiple sclerosis	1.35e-05	0.000229	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—POMC—multiple sclerosis	1.3e-05	0.00022	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—POMC—multiple sclerosis	1.29e-05	0.000219	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	1.29e-05	0.000219	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—POMC—multiple sclerosis	1.28e-05	0.000217	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	1.27e-05	0.000215	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	1.26e-05	0.000215	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	1.25e-05	0.000212	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.24e-05	0.000211	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	1.24e-05	0.00021	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	1.23e-05	0.000208	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.17e-05	0.000198	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	1.15e-05	0.000195	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	1.15e-05	0.000195	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	1.15e-05	0.000194	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	1.14e-05	0.000193	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—APOE—multiple sclerosis	1.08e-05	0.000183	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MYC—multiple sclerosis	1.06e-05	0.000181	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	1.06e-05	0.00018	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	1.04e-05	0.000177	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL2—multiple sclerosis	9.59e-06	0.000163	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL2—multiple sclerosis	9.55e-06	0.000162	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	9.54e-06	0.000162	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	9.51e-06	0.000161	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL2—multiple sclerosis	9.46e-06	0.000161	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	9.41e-06	0.00016	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—POMC—multiple sclerosis	9.24e-06	0.000157	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	9.07e-06	0.000154	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	9.04e-06	0.000153	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	8.96e-06	0.000152	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ALB—multiple sclerosis	8.43e-06	0.000143	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	8.07e-06	0.000137	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	8.04e-06	0.000136	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IL6—multiple sclerosis	8e-06	0.000136	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	7.96e-06	0.000135	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MYC—multiple sclerosis	7.49e-06	0.000127	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	7.48e-06	0.000127	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MYC—multiple sclerosis	7.47e-06	0.000127	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	7.45e-06	0.000126	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MYC—multiple sclerosis	7.4e-06	0.000126	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	7.38e-06	0.000125	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	7.33e-06	0.000124	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	7.31e-06	0.000124	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	7.24e-06	0.000123	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOE—multiple sclerosis	7.03e-06	0.000119	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—POMC—multiple sclerosis	6.04e-06	0.000103	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL6—multiple sclerosis	5.63e-06	9.56e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL6—multiple sclerosis	5.62e-06	9.53e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL6—multiple sclerosis	5.56e-06	9.44e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALB—multiple sclerosis	5.51e-06	9.35e-05	CbGpPWpGaD
